Holen Sie sich die Stockscreener-App
3.19
2.15%
-0.07
Handel nachbörslich:
3.10
-0.09
-2.82%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SAVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$3.26
Offen:
$3.3
24-Stunden-Volumen:
941.88K
Relative Volume:
0.38
Marktkapitalisierung:
$154.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-97.22M
KGV:
-2.3116
EPS:
-1.38
Netto-Cashflow:
$-82.44M
1W Leistung:
-16.05%
1M Leistung:
-12.12%
6M Leistung:
+98.14%
1J Leistung:
-87.83%
1-Tages-Spanne:
$3.045
$3.32
1-Wochen-Bereich:
$3.045
$3.81
52-Wochen-Spanne:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Firmenname
Cassava Sciences Inc
Sektor
Branche
Telefon
512-501-2444
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Vergleichen Sie SAVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
3.19 | 157.48M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-27 | Eingeleitet | B. Riley Securities | Buy |
| 2021-02-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-01-10 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten
Will Cassava Sciences Inc. Equity Warrant stock benefit from green energy trendsJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
Why Cassava Sciences Inc. Equity Warrant is moving todayWeekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Why Cassava Sciences Inc. stock is favored by pension fundsTrade Volume Summary & Technical Pattern Based Signals - newser.com
Can RSWM Limited Maintain Its Share of Global Market for Its ProductVolume Spike Alerts & Achieve Explosive Results - earlytimes.in
Why Cassava Sciences Inc. (PX91) stock appeals to dividend investorsBuy Signal & Verified Short-Term Plans - newser.com
Why analysts upgrade Cassava Sciences Inc. stockJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Can Cassava Sciences Inc. Equity Warrant stock maintain operating marginsBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
How institutional ownership impacts Cassava Sciences Inc. Equity Warrant stockStock Surge & Safe Swing Trade Setup Alerts - newser.com
Tools to monitor Cassava Sciences Inc. Equity Warrant recovery probabilityDay Trade & AI Enhanced Execution Alerts - newser.com
What risks investors should watch in Cassava Sciences Inc. stock2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Full technical analysis of Cassava Sciences Inc. stock2025 Macro Impact & Short-Term High Return Strategies - newser.com
What analyst consensus says on Cassava Sciences Inc. stockJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - newser.com
Will Cassava Sciences Inc. continue its uptrendEntry Point & Stepwise Trade Signal Implementation - newser.com
Is it too late to sell Cassava Sciences Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Cassava Sciences Inc. Equity Warrant stock volume spike explainedEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Will Cassava Sciences Inc. Equity Warrant stock deliver shareholder valueBear Alert & Daily Stock Trend Watchlist - newser.com
How currency fluctuations impact Cassava Sciences Inc. stockJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
Is Cassava Sciences Inc. Equity Warrant stock bottoming outJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Why Cassava Sciences Inc. (PX91) stock could be next leaderLayoff News & Accurate Intraday Trading Signals - newser.com
Can Cassava Sciences Inc. stock attract ESG capital inflowsJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Is Cassava Sciences Inc. stock a buy on dipsGDP Growth & Weekly Market Pulse Alerts - newser.com
Risk adjusted return profile for Cassava Sciences Inc. analyzedMarket Trend Summary & Daily Momentum Trading Reports - newser.com
Why Cassava Sciences Inc. stock is in analyst buy zoneWeekly Trading Summary & Pattern Based Trade Signal System - newser.com
Is Cassava Sciences Inc. Equity Warrant stock affected by interest rate hikesAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Will Cassava Sciences Inc. Equity Warrant stock keep outperforming rivalsJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com
What to expect from Cassava Sciences Inc. in the next 30 daysPortfolio Risk Report & Daily Chart Pattern Signal Reports - newser.com
Will Cassava Sciences Inc. Equity Warrant stock benefit from sector rotationM&A Rumor & Verified Swing Trading Watchlists - newser.com
Why Cassava Sciences Inc. Equity Warrant stock is a value investor pickM&A Rumor & Stock Portfolio Risk Control - newser.com
Can Cassava Sciences Inc. (PX91) stock ride next bull market cycleSell Signal & Technical Analysis for Trade Confirmation - newser.com
Will Cassava Sciences Inc. stock go up soon2025 Risk Factors & Consistent Growth Equity Picks - newser.com
How strong is Cassava Sciences Inc. stock revenue growth2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Will Cassava Sciences Inc. (PX91) stock benefit from mergers2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
Chart overlay techniques for tracking Cassava Sciences Inc.July 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
Finanzdaten der Cassava Sciences Inc-Aktie (SAVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):